Compare IMMP & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMMP | BODI |
|---|---|---|
| Founded | 1987 | 1998 |
| Country | Australia | United States |
| Employees | N/A | 270 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5M | 34.3M |
| IPO Year | 2012 | 2020 |
| Metric | IMMP | BODI |
|---|---|---|
| Price | $3.60 | $4.57 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | ★ 303.6K | 19.1K |
| Earning Date | 09-01-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 96.10 |
| EPS | N/A | ★ 0.47 |
| Revenue | N/A | ★ $251,727,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.09 |
| P/E Ratio | ★ N/A | $9.79 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.26 | $4.05 |
| 52 Week High | $5.36 | $16.87 |
| Indicator | IMMP | BODI |
|---|---|---|
| Relative Strength Index (RSI) | 67.55 | 35.00 |
| Support Level | $2.65 | $4.54 |
| Resistance Level | $5.36 | $5.11 |
| Average True Range (ATR) | 0.22 | 0.25 |
| MACD | 0.11 | 0.10 |
| Stochastic Oscillator | 64.73 | 35.63 |
Immutep Ltd is a clinical-stage biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.
The Beachbody Co Inc is a fitness and nutrition company providing fitness, nutrition, and stress-reducing programs to its customers. a results-oriented company at the intersection of wellness, technology, and media. The company developed one of the original fitness digital streaming platforms with an extensive library of content containing streaming programs and streaming videos. Company products include Digital Subscriptions, Nutritional Products, and Connected Fitness Products, where the majority of revenue is from Digital Subscriptions. The Company has one operating and reporting segment. Geographically operates in the USA and the rest of the world, with maximum revenue from the United States.